

> The following tables of spectra of activity for different antibiotics are generalizations. Sensitivity data at your own institution should be used to guide therapy.


# ANTIBIOTICS

_The following tables of spectra of activity for different antibiotics are generalizations. Sensitivity data at your own institution should be used to guide therapy._

<table><colgroup><col> <col> <col></colgroup><tbody><tr><td colspan="3"><p>Penicillins</p></td></tr><tr><td><p><b>Generation</b></p></td><td><p><b>Properties</b></p></td><td><p><b>Spectrum</b></p></td></tr><tr><td><p><b>Natural</b><br>(eg, penicillin)</p></td><td><p>Some GPC, GPR, GNC, many anaerobes (not <i>Bacteroides</i>)</p></td><td><p>Group A strep, Enterococci, <i>Listeria, Pasteurella, Actinomyces</i>, Syphilis</p></td></tr><tr><td><p><b>Anti-staph</b><br>(eg, nafcillin)</p></td><td><p>Active vs. PCNase-producing Staph Little activity vs. Gram ⊖</p></td><td><p>Staphylococci (except MRSA) Streptococci</p></td></tr><tr><td><p><b>Amino</b><br>(eg, ampicillin)</p></td><td><p>Penetrate porin channel of Gram ⊖<br>Not stable against PCNases</p></td><td><p><i>E. coli, Proteus, Listeria, H. influenzae Salmonella, Shigella, Enterococci</i></p></td></tr><tr><td><p><b>Extended</b><br>(eg, piperacillin)</p></td><td><p>Penetrate porin channel of Gram ⊖<br>More resistant to PCNases</p></td><td><p>Most GNR incl. <i>Enterobacter, Pseudomonas, Serratia</i></p></td></tr><tr><td><p><b>Carbapenems</b><br>(eg, imipenem)</p></td><td><p>Resistant to most β-lactamases</p></td><td><p>Most Gram ⊕ &amp; ⊖, incl. anaerobes; <i>not</i> MRSA or VRE</p></td></tr><tr><td><p><b>Monobactams</b><br>(aztreonam)</p></td><td><p>Active vs. Gram ⊖ but not Gram ⊕</p></td><td><p>Gram ⊖ bacterial infxn in Pt with PCN or Ceph allergy</p></td></tr><tr><td><p>β<b>-lact. inhib.</b><br>(eg, sulbactam, clavulanate)</p></td><td><p>Inhibit plasma-mediated β-lactamases</p></td><td><p>Adds staph, <i>B. fragilis</i>, &amp; some GNR (<i>H. flu, M. cat</i>, some <i>E. coli</i>); intrinsic activity against <i>Acinetobacter</i></p></td></tr></tbody></table>

<table><colgroup><col> <col> <col></colgroup><tbody><tr><td colspan="3"><p>Cephalosporins</p></td></tr><tr><td colspan="3"><p><i>Resistant to most</i> β<i>-lactamases. No activity vs. enterococci.</i></p></td></tr><tr><td><p>Gen.</p></td><td><p>Spectrum</p></td><td><p>Indications</p></td></tr><tr><td><p><b>1<sup>st</sup></b> (eg, cefazolin)</p></td><td><p>Most GPC (incl. staph &amp; strep, not MRSA); some GNR (incl. <i>E. coli, Proteus, Klebsiella</i>)</p></td><td><p>Used for surgical Ppx &amp; skin infxns</p></td></tr><tr><td><p><b>2<sup>nd</sup></b> (eg, cefuroxime, cefotetan)</p></td><td><p>↓ activity vs. GPC, ↑ vs. GNR. 2 subgroups:</p><p>Resp: <i>H. influenzae</i> &amp; <i>M. catarrhalis</i></p><p>GI/GU: ↑ activity vs. <i>B. fragilis</i></p></td><td><p>PNA/COPD flare</p><p>Abdominal infxns</p></td></tr><tr><td><p><b>3<sup>rd</sup></b> (eg, ceftriaxone, ceftazidime)</p></td><td><p>Broad activity vs. GNR &amp; some anaerobes. Ceftazidime active vs. <i>Pseudomonas</i>.</p></td><td><p>PNA, sepsis, meningitis</p></td></tr><tr><td><p><b>4<sup>th</sup></b> (eg, cefepime)</p></td><td><p>↑ resistance to β-lactamases (incl. of staph and <i>Enterobacter</i>)</p></td><td><p>Similar to 3<sup>rd</sup> gen. MonoRx for nonlocalizing febrile neutropenia</p></td></tr><tr><td><p><b>5<sup>th</sup></b> (eg, ceftaroline)</p></td><td><p>Only class of cephalosporin with MRSA activity. NOT active vs. <i>Pseudomonas</i>.</p></td><td><p>MRSA. Not 1<sup>st</sup> line for MRSA bacteremia.</p></td></tr><tr><td><p><b>Combination</b> (eg, ceftolozane-tazobactam, ceftazidime-avibactam)</p></td><td><p>MDR GNRs, incl. <i>Pseudomonas</i>. Ceftaz-avi has activity vs. some carbapenemases.</p></td><td><p>Complicated UTIs, complicated intra-abdominal infections.</p></td></tr></tbody></table>

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p>Other Antibiotics</p></td></tr><tr><td><p>Antibiotic</p></td><td><p>Spectrum</p></td></tr><tr><td><p><b>Vancomycin</b></p></td><td><p>Gram ⊕ bacteria incl. MRSA, PCNase-producing pneumococci and enterococci (except VRE)</p></td></tr><tr><td><p><b>Linezolid</b></p></td><td rowspan="2"><p>GPC incl. MRSA &amp; VRE (check susceptibility for VRE)</p></td></tr><tr><td><p><b>Daptomycin</b></p></td></tr><tr><td><p><b>Quinolones</b></p></td><td><p>Enteric GNR &amp; atypicals. 3<sup>rd</sup> &amp; 4<sup>th</sup> gen. ↑ activity vs. Gram ⊕.</p></td></tr><tr><td><p><b>Aminoglycosides</b></p></td><td><p>GNR. Synergy with cell-wall active 抗生素 (β-lactam, vanco) vs. GPC.<br>↓ activity in low pH (eg, abscess). No activity vs. anaerobes.</p></td></tr><tr><td><p><b>Macrolides</b></p></td><td><p>GPC, some respiratory Gram, atypicals</p></td></tr><tr><td><p><b>TMP/SMX</b></p></td><td><p>Some enteric GNR, <i>Stenotrophomonas</i>, PCP, <i>Nocardia, Toxo</i>, most community-acquired MRSA</p></td></tr><tr><td><p><b>Clindamycin</b></p></td><td><p>Most Gram ⊕ (except enterococci) &amp; anaerobes (↑ resis. to <i>B. fragilis</i>)</p></td></tr><tr><td><p><b>Metronidazole</b></p></td><td><p>Almost all anaerobic Gram, most anaerobic Gram ⊕</p></td></tr><tr><td><p><b>Doxycycline</b></p></td><td><p><i>Rickettsia, Ehrlichia, Anaplasma, Chlamydia, Mycoplasma, Nocardia</i>, Lyme</p></td></tr><tr><td><p><b>Tigecycline</b></p></td><td><p>Many GPC incl. MRSA &amp; VRE; some GNR incl. ESBL but not <i>Pseudomonas</i> or <i>Proteus.</i></p></td></tr></tbody></table>

![](https://i.imgur.com/DyFEhbu.jpg)
